These models are also capable of stratifying RA patients by serological status and distinguishing them from healthy individuals, based on combinations of markers like rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and clinical symptoms. This evidence concerns the gene PRTN3 and rheumatoid arthritis.